Comparison of allocation strategies of convalescent plasma to reduce excess infections and mortality from <scp>SARS‐CoV</scp> ‐2 in a <scp>US</scp> ‐like population-Reference-Cited by-同舟云学术

Comparison of allocation strategies of convalescent plasma to reduce excess infections and mortality from SARS‐CoV ‐2 in a US ‐like population

Published:2022-11-24 Issue:1 Volume:63 Page:92-103
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Kostandova Natalya¹^ORCID,Drabo Emmanuel Fulgence²^ORCID,Yenokyan Karine¹^ORCID,Wesolowski Amy¹^ORCID,Truelove Shaun¹³^ORCID,Bloch Evan M.⁴^ORCID,Tobian Aaron A. R.⁴^ORCID,Vassallo Ralph R.⁵^ORCID,Bravo Marjorie D.⁵^ORCID,Casadevall Arturo⁶^ORCID,Lessler Justin¹⁷⁸^ORCID,Lau Bryan¹

Affiliation:

1. Department of Epidemiology, Bloomberg School of Public Health Johns Hopkins University Baltimore Maryland USA

2. Department of Health Policy and Management, Bloomberg School of Public Health Johns Hopkins University Baltimore Maryland USA

3. Department of International Health, Bloomberg School of Public Health Johns Hopkins University Baltimore Maryland USA

4. Division of Transfusion Medicine, Department of Pathology, School of Medicine Johns Hopkins University Baltimore Maryland USA

5. Vitalant Medical Affairs Scottsdale Arizona USA

6. Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health Johns Hopkins University Baltimore Maryland USA

7. Department of Epidemiology, Gillings School of Global Public Health University of North Carolina Chapel Hill North Carolina USA

8. Carolina Population Center University of North Carolina Chapel Hill North Carolina USA

Funder

Burroughs Wellcome Fund

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.17174

Reference38 articles.

1. WHO Coronavirus (COVID‐19) Dashboard [Internet]. [cited 2022 Feb 17]. Available from:https://covid19.who.int

2. Effectiveness of convalescent plasma therapy in severe COVID-19 patients

3. Safety Update

4. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review

5. Convalescent plasma for COVID-19: a meta-analysis, trial sequential analysis, and meta-regression

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Equitable Allocation of Scarce Resources During the Covid-19 Pandemic: A Case Study for Convalescent Plasma Distribution;2023 Winter Simulation Conference (WSC);2023-12-10